Hepatitis B: Pipeline Analysis H1 2018; Assessment by Target, Mechanism of Action, Route of Administration, and Molecule Type - ResearchAndMarkets.com

DUBLIN--()--The "Hepatitis B - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.

This latest pipeline guide provides comprehensive information on the therapeutics under development for Hepatitis B (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hepatitis B (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis B and features dormant and discontinued projects.

The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 9, 26, 24, 1, 69, 29 and 5 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 3, 1, 9 and 3 molecules, respectively.

Key Topics Covered

  1. Introduction
  2. Hepatitis B - Overview
  3. Hepatitis B - Therapeutics Development
  4. Hepatitis B - Therapeutics Assessment
  5. Hepatitis B - Companies Involved in Therapeutics Development
  6. Hepatitis B - Drug Profiles
  7. Hepatitis B - Dormant Projects
  8. Hepatitis B - Discontinued Products
  9. Hepatitis B - Product Development Milestones
  10. Appendix

Companies Mentioned

  • Abivax SA
  • AiCuris GmbH & Co KG
  • Altimmune Inc
  • Altravax Inc
  • Arcturus Therapeutics Ltd
  • Arrowhead Pharmaceuticals Inc
  • Benitec Biopharma Ltd
  • Biological E Ltd
  • Bukwang Pharm Co Ltd
  • Cadila Healthcare Ltd
  • CaroGen Corp
  • Celltrion Inc
  • Dicerna Pharmaceuticals Inc
  • Enyo Pharma SA
  • Excision BioTherapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc
  • ISA Pharmaceuticals BV
  • Jiangsu Hansoh Pharmaceutical Group Co Ltd
  • Johnson & Johnson
  • LG Chem Ltd
  • Microbiotix Inc
  • Samjin Pharm Co Ltd
  • Sanofi Pasteur SA
  • Scynexis Inc
  • Shantha Biotechnics Pvt Ltd
  • Sino Biopharmaceutical Ltd
  • Spring Bank Pharmaceuticals Inc
  • TCM Biotech International Corp
  • Theravectys SA
  • Transgene SA
  • ViroStatics srl
  • VLP Biotech Inc

For more information about this report visit https://www.researchandmarkets.com/research/b99pj7/hepatitis_b?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs